Skip to main content

Table 1 The demographic and clinical data of the patients with RB and healthy controls

From: Quantitative evaluation of retinal microvasculature and retrobulbar vessels after intravenous chemotherapy for retinoblastoma

  Group I Group II Control P value
Number of subjects 10 10 10  
Age (years) 9.7 ± 2.4 8.8 ± 2.3 9.6 ± 1.7  
Gender, n
 Male 5 4 6  
 Female 5 6 4  
Tumor consolidation, n
 Cryotherapy 8 0 0  
 TTT 9 0 0  
 Cryotherapy + TTT 7 0 0  
BCVA (logMAR) 0 0 0  
Axial Length (mm) 23.0 ± 1.1 22.9 ± 0.8 23.1 ± 0.7  
First presentation time (mouth) (mouth) 12.9 ± 7.7 30.1 ± 9.6   0.0003
Duration time (year) 8.2 ± 2.4 7.3 ± 2.4   0.4127
IVC times 6.5 ± 1.6 6.5 ± 1.6   1
Family history, n (%) 1(10%) 0   
  1. Values are expressed as the mean ± SD. p < 0.05 was considered statistically significant
  2. BCVA Best-corrected visual acuity, logMAR Logarithm of the minimum angle of resolution, IVC Intravenous chemotherapy. Duration time Duration from last IVC to time of the exam